NCT00456235View on ClinicalTrials.gov

Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2011

Conditions
Liver Transplantation
Interventions
DRUG

Mycophénolate Mofétil

DRUG

Ciclosporine A

DRUG

Tacrolimus

Trial Locations (17)

13385

CHU de Marseille, Marseille

14033

CHU de Caen, Caen

25030

CHU de Besançon, Besançon

31059

CHU de Toulouse, Toulouse

33076

CHU de Bordeaux, Bordeaux

34295

CHU de Montpellier, Montpellier

35033

CHU de Rennes, Rennes

38043

CHU de Grenoble, Grenoble

59000

CHU de Lille, Lille

67098

CHU de Strasbourg, Strasbourg

69437

Hôpital Edouard Herriot, Lyon

75012

Hôpital Saint Antoine, Paris

75014

Hôpital Cochin, Paris

92000

Hôpital Beaujon, Clichy

94010

Hôpital Henri Mondor, Créteil

94804

Hôpital Paul Brousse, Villejuif

06200

CHU de Nice, Nice

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT00456235 - Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors | Biotech Hunter | Biotech Hunter